Concepts (233)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Acute Coronary Syndrome
- Acute-Phase Proteins
- Acyl Coenzyme A
- Adenosine
- Adiponectin
- Adjuvants, Immunologic
- Adolescent
- Adrenergic beta-Antagonists
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Allylamine
- Angina, Unstable
- Angioplasty, Balloon, Coronary
- Angiotensin-Converting Enzyme Inhibitors
- Animals
- Anti-Bacterial Agents
- Anticholesteremic Agents
- Anti-Infective Agents, Local
- Antioxidants
- Aortic Valve Stenosis
- Apolipoprotein A-I
- Apolipoproteins
- Arterial Occlusive Diseases
- Arteriosclerosis
- Atherosclerosis
- Azetidines
- Biological Transport
- Biomarkers
- Blood Coagulation
- Blood Pressure
- Bone Nails
- Brain
- Cardiac Catheterization
- Cardiac Output, Low
- Cardiac Surgical Procedures
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Agents
- Cardiovascular Diseases
- Cardiovascular Physiological Phenomena
- Carotid Artery Diseases
- Central Nervous System
- Child
- Chlorhexidine
- Cholesterol
- Cholesterol, HDL
- Cholesterol, LDL
- Cholestyramine Resin
- Clinical Trials as Topic
- Clofibrate
- Clofibric Acid
- Cocaine
- Colesevelam Hydrochloride
- Colestipol
- Collagen
- Combined Modality Therapy
- Coronary Angiography
- Coronary Artery Bypass
- Coronary Artery Disease
- Coronary Circulation
- Coronary Disease
- Coronary Occlusion
- Coronary Thrombosis
- Coronary Vessels
- Cost-Benefit Analysis
- C-Reactive Protein
- Cytokines
- Diabetes Complications
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diltiazem
- Disease Models, Animal
- Disease Progression
- Diuretics
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Interactions
- Drug Therapy, Combination
- Drug-Eluting Stents
- Dyslipidemias
- Echocardiography
- Endocarditis
- Endothelium, Vascular
- Energy Metabolism
- Enzyme Inhibitors
- Etanercept
- Evaluation Studies as Topic
- Ezetimibe
- Fasting
- Fatty Acids, Monounsaturated
- Female
- Fenofibrate
- Fibric Acids
- Fibrinolytic Agents
- Fistula
- Follow-Up Studies
- Fracture Fixation, Intramedullary
- Gemfibrozil
- Gene Deletion
- Genetic Predisposition to Disease
- Genotype
- Greece
- Heart Failure
- Heart Transplantation
- Heart Valve Prosthesis Implantation
- Heart-Assist Devices
- Hematologic Agents
- Heptanoic Acids
- HIV Infections
- Homeostasis
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemia Type II
| - Hypertension
- Hypertrophy
- Hypolipidemic Agents
- Hypolipoproteinemias
- Immunoglobulin G
- Immunoglobulins, Intravenous
- Indoles
- Inflammation
- Inflammation Mediators
- Insulin
- Insulin Resistance
- Intestinal Absorption
- Isosorbide Dinitrate
- Leptin
- Lipid Metabolism
- Lipids
- Lipolysis
- Lipoprotein(a)
- Lipoproteins
- Lipoproteins, HDL
- Lipoproteins, IDL
- Lipoproteins, LDL
- Lipoproteins, VLDL
- Liver
- Logistic Models
- Lovastatin
- Male
- Metabolic Syndrome
- Metoprolol
- Mice
- Middle Aged
- Morbidity
- Multicenter Studies as Topic
- Muscle, Skeletal
- Musculoskeletal Pain
- Mutation
- Myocardial Contraction
- Myocardial Infarction
- Myocardial Ischemia
- Myocarditis
- Myocardium
- Myocytes, Cardiac
- Myositis
- Naphthalenes
- Neoplasms
- Neovascularization, Physiologic
- Niacin
- Obesity
- Oxidation-Reduction
- Oxidative Stress
- Parasympathetic Nervous System
- Pentoxifylline
- Peptidyl-Dipeptidase A
- Pilot Projects
- Placebos
- Plasminogen Activator Inhibitor 1
- Platelet Aggregation Inhibitors
- Platelet Function Tests
- Platelet Glycoprotein GPIIb-IIIa Complex
- Polymorphism, Genetic
- Postoperative Complications
- Postprandial Period
- Practice Guidelines as Topic
- Pravastatin
- Premedication
- Prevalence
- Probucol
- Prognosis
- Prospective Studies
- Pulmonary Artery
- Pyridines
- Pyrroles
- Rabbits
- Radiography
- Radiology, Interventional
- Radionuclide Angiography
- Random Allocation
- Randomized Controlled Trials as Topic
- Receptors, Tumor Necrosis Factor
- Recombinant Fusion Proteins
- Regression Analysis
- Renin-Angiotensin System
- Resistin
- Retrospective Studies
- Rhabdomyolysis
- Risk Assessment
- Risk Factors
- Risk Reduction Behavior
- Sensitivity and Specificity
- Severity of Illness Index
- Signal Transduction
- Simvastatin
- Staphylococcal Infections
- Stroke
- Substance Abuse, Intravenous
- Survival Analysis
- Survival Rate
- Sympathetic Nervous System
- Thallium Radioisotopes
- Tibial Fractures
- Time Factors
- T-Lymphocytes
- Tomography, Emission-Computed, Single-Photon
- Treatment Outcome
- Triglycerides
- Tumor Necrosis Factor-alpha
- Tyrosine
- United Kingdom
- United States
- Vascular Patency
- Vasoconstriction
- Vasoconstrictor Agents
- Vasodilator Agents
- Ventricular Dysfunction, Left
- Visual Acuity
- Xylenes
|
FARMER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(11)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_